3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Leukemia, Myeloid, Acute
49
Neoplasm Metastasis
46
Multiple Myeloma
40
Breast Neoplasms
33
Prostatic Neoplasms
30
Colorectal Neoplasms
27
Lymphoma
26
Lung Neoplasms
26
Leukemia, Lymphocytic, Chronic, B-Cell
24
Pancreatic Neoplasms
23
Myelodysplastic Syndromes
22
Lymphoma, Large B-Cell, Diffuse
21
Triple Negative Breast Neoplasms
19
Ovarian Neoplasms
17
Melanoma
17
Carcinoma, Non-Small-Cell Lung
17
Burkitt Lymphoma
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Neoplasms
15
Carcinoma, Renal Cell
15
Leukemia, Myelomonocytic, Chronic
13
Glioma
13
Neuroblastoma
12
Lymphoma, Mantle-Cell
12
Lymphoma, Follicular
12
Sarcoma
11
Lymphoma, Non-Hodgkin
11
Fallopian Tube Neoplasms
11
Endometrial Neoplasms
11
Myeloproliferative Disorders
10
Interventions
relatlimab
1
pembrolizumab
1
enfortumab vedotin
1
darolutamide
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Radiotherapy
1
Radiation Dose Hypofractionation
1
Pregnancy Tests
1
Nivolumab
1
Mitomycin
1
Human Papillomavirus DNA Tests
1
Gemcitabine
1
Fluorouracil
1
Colposcopy
1
Cisplatin
1
Biopsy
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Urogenital Diseases
×
Biopsy
×
1 year
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled